# MyMD Pharmaceuticals Inc. (MYMD)

Source: https://www.quantisnow.com/company/MYMD
Generated: 2026-11-06T21:17:33.051Z

- Ticker: MYMD
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IPO year: 2014
- Website: mymd.com

## About

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, engages in the development of drug candidates to treat autoimmune, and aging and age-related diseases. It is developing MYMD-1, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel diseases, as well as to treat age-related illnesses such as, frailty and sarcopenia. The company is also developing Supera-CBD, a synthetic preclinical cannabidiol derivative that targets CB2 receptors. The company is based in Baltimore, Maryland.

## Latest MYMD news and filings

- 2024-07-24 13:07 UTC [Market Chatter] [TNF Pharmaceuticals Trades Under New Ticker "TNFA"](https://www.quantisnow.com/insight/tnf-pharmaceuticals-trades-under-new-ticker-tnfa-5624433)
- 2024-07-24 13:05 UTC [TNF Pharmaceuticals (Formerly MyMD Pharmaceuticals) Begins Trading Under New Nasdaq Stock Symbol "TNFA" Effective Before Market Open Today](https://www.quantisnow.com/insight/tnf-pharmaceuticals-formerly-mymd-pharmaceuticals-begins-trading-under-new-nasdaq-5624421)
- 2024-07-22 13:02 UTC [Market Chatter] [MyMD Pharmaceuticals Announces Corporate Rebranding To New Name TNF Pharmaceuticals, To Begin Under The New Trading Symbol "TNFA" Effective July 24, 2024](https://www.quantisnow.com/insight/mymd-pharmaceuticals-announces-corporate-rebranding-to-new-name-tnf-pharmaceuticals-5619211)
- 2024-07-22 13:00 UTC [MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.](https://www.quantisnow.com/insight/mymd-pharmaceuticals-announces-corporate-rebranding-to-new-name-tnf-pharmaceuticals-5619181)
- 2024-07-01 21:15 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-mymd-pharmaceuticals-inc-5587408)
- 2024-06-28 20:05 UTC [SEC Form 3] [SEC Form 3 filed by new insider Friscia Stephen](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-friscia-stephen-5583799)
- 2024-06-26 00:50 UTC [Market Insight] [Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More](https://www.quantisnow.com/insight/latest-key-hires-board-changes-in-cannabis-industry-canopy-growth-5577149)
- 2024-06-24 20:23 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-5573871)
- 2024-06-21 21:14 UTC [SEC Form S-3] [SEC Form S-3 filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-mymd-pharmaceuticals-inc-5571674)
- 2024-06-20 21:20 UTC [SEC Form 8-K] [Amendment: MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/amendment-mymd-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-5569324)
- 2024-06-20 20:15 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-mymd-pharmaceuticals-inc-5568713)
- 2024-06-17 13:04 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5561139)
- 2024-06-17 13:03 UTC [Market Chatter] [MyMD Pharmaceuticals Announces Dr. Mitchell Glass As President And CMO](https://www.quantisnow.com/insight/mymd-pharmaceuticals-announces-dr-mitchell-glass-as-president-and-cmo-5561126)
- 2024-06-17 13:00 UTC [Leadership Update] [MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer](https://www.quantisnow.com/insight/mymd-pharmaceuticals-appoints-accomplished-biopharmaceutical-leader-and-current-board-member-5561089)
- 2024-06-04 12:06 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-5534505)
- 2024-05-31 12:00 UTC [SEC Form D] [SEC Form D filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-mymd-pharmaceuticals-inc-5528012)
- 2024-05-31 12:00 UTC [SEC Form D] [SEC Form D filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-mymd-pharmaceuticals-inc-5528004)
- 2024-05-30 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-after-market-session-5526779)
- 2024-05-30 20:05 UTC [SEC Form 3] [SEC Form 3 filed by new insider Pharmacyte Biotech, Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-pharmacyte-biotech-inc-5526299)
- 2024-05-30 20:05 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-mymd-pharmaceuticals-inc-5526284)
- 2024-05-23 20:05 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-material-modification-to-5513546)
- 2024-05-21 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5507708)
- 2024-05-21 13:41 UTC [Market Chatter] [PharmaCyte Biotech Makes $7M Investment In MyMD Pharmaceuticals; Investment In Life Sciences Solidifies Previously Announced Strategy To Utilize Significant Cash Position To Create Additional Stockholder Value](https://www.quantisnow.com/insight/pharmacyte-biotech-makes-7m-investment-in-mymd-pharmaceuticals-investment-in-5506483)
- 2024-05-21 13:10 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5506391)
- 2024-05-21 13:00 UTC [PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease](https://www.quantisnow.com/insight/pharmacyte-biotech-makes-7-million-strategic-investment-in-mymd-a-5506336)
- 2024-05-21 13:00 UTC [Public Offering] [MyMD Pharmaceuticals Secures Strategic Investments](https://www.quantisnow.com/insight/mymd-pharmaceuticals-secures-strategic-investments-5506335)
- 2024-05-16 21:30 UTC [SEC Form 3] [SEC Form 3 filed by new insider Glass Mitchell](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-glass-mitchell-5498218)
- 2024-05-15 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mymd-pharmaceuticals-inc-5494349)
- 2024-04-18 20:30 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-5419179)
- 2024-04-09 17:12 UTC [Market Insight] [Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-tilray-brands-shares-are-trading-lower-by-around-22-5400291)
- 2024-04-09 13:30 UTC [Market Chatter] [MyMD Pharmaceuticals Filing From Late Monday Shows Co. Entered Omnibus Waiver And Amendment Agreement With Required Holders Under Previously Announced Securities Purchase Agreement](https://www.quantisnow.com/insight/mymd-pharmaceuticals-filing-from-late-monday-shows-co-entered-omnibus-5399864)
- 2024-04-09 12:09 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-5399406)
- 2024-04-09 10:05 UTC [Market Insight] [Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-biophytis-shares-are-trading-higher-by-around-55-here-5398919)
- 2024-04-08 20:49 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5398301)
- 2024-04-01 21:29 UTC [SEC Form 10-K] [SEC Form 10-K filed by MyMD Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-mymd-pharmaceuticals-inc-5381990)
- 2024-03-26 20:30 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-amendments-to-articles-5369702)
- 2024-03-07 21:30 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5327432)
- 2024-03-05 16:00 UTC [SEC Form 8-K] [MyMD Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mymd-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5316564)
- 2024-03-05 14:21 UTC [Market Chatter] [MyMD Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement For Continued Listing](https://www.quantisnow.com/insight/mymd-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement-5316256)
- 2024-03-05 14:15 UTC [MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing](https://www.quantisnow.com/insight/mymd-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement-5316226)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MYMD
- Earnings history: https://www.quantisnow.com/earnings/MYMD
- Dividend history: https://www.quantisnow.com/dividends/MYMD
- Insider transactions: https://www.quantisnow.com/insiders/MYMD
- Options chain: https://www.quantisnow.com/options/MYMD
- SEC 8-K filings only: https://www.quantisnow.com/company/MYMD/8-k
- RSS and alerts for MYMD: https://www.quantisnow.com/docs/rss-feeds.md